Cargando…
A practical approach for PD-L1 evaluation in gastroesophageal cancer
PD-L1 is an established predictive immunohistochemical biomarker of response to immune checkpoint inhibitors. At present, PD-L1 is routinely assessed on biopsy samples of advanced gastroesophageal cancer patients before initiating first-line treatment. However, PD-L1 is still a suboptimal biomarker,...
Autores principales: | Angerilli, Valentina, Fassan, Matteo, Parente, Paola, Gullo, Irene, Campora, Michela, Rossi, Chiara, Sacramento, Maria Luisa, Pennelli, Gianmaria, Vanoli, Alessandro, Grillo, Federica, Mastracci, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462995/ https://www.ncbi.nlm.nih.gov/pubmed/36537078 http://dx.doi.org/10.32074/1591-951X-836 |
Ejemplares similares
-
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
por: Mastracci, Luca, et al.
Publicado: (2022) -
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes
por: Angerilli, Valentina, et al.
Publicado: (2022) -
Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions
por: Businello, Gianluca, et al.
Publicado: (2021) -
Gut inflammation and tumorigenesis: every site has a different tale to tell
por: Vanoli, Alessandro, et al.
Publicado: (2023) -
Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes
por: Gullo, Irene, et al.
Publicado: (2020)